世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2015年
41期
31-32
,共2页
莫沙必利片%复方阿嗪米特肠溶片%肝硬化腹胀
莫沙必利片%複方阿嗪米特腸溶片%肝硬化腹脹
막사필리편%복방아진미특장용편%간경화복창
mosapride tablets%compound azintamide enteric-coated tablets abdominal distension%liver cirrhosis
目的:了解探析肝硬化腹胀患者接受莫沙必利片联合复方阿嗪米特肠溶片治疗的临床效果及推广价值。方法随机纳入本院2013年2月-2014年8月收治肝硬化腹胀患者30例,接受莫沙必利片联合复方阿嗪米特肠溶片治疗方案,设为观察组,另随机纳入本院同期收治应用常规药物方案治疗肝硬化腹胀患者30例,设为对照组。对比2组患者临床治疗效果及各项临床指标情况。结果完成疗程后,对2组患者临床疗效进行评估对比,观察组患者疗效显著优于对照组,差异有统计学价值(P<0.05);对比2组患者治疗前后症状积分,观察组患者改善情况显著优于对照组,差异有统计学价值(P<0.05)。结论对肝硬化腹胀患者应用莫沙必利片联合复方阿嗪米特肠溶片治疗不但疗效显著且可有效改善患者临床症状,保障临床治疗效果及生活质量,值得临床普及推广。
目的:瞭解探析肝硬化腹脹患者接受莫沙必利片聯閤複方阿嗪米特腸溶片治療的臨床效果及推廣價值。方法隨機納入本院2013年2月-2014年8月收治肝硬化腹脹患者30例,接受莫沙必利片聯閤複方阿嗪米特腸溶片治療方案,設為觀察組,另隨機納入本院同期收治應用常規藥物方案治療肝硬化腹脹患者30例,設為對照組。對比2組患者臨床治療效果及各項臨床指標情況。結果完成療程後,對2組患者臨床療效進行評估對比,觀察組患者療效顯著優于對照組,差異有統計學價值(P<0.05);對比2組患者治療前後癥狀積分,觀察組患者改善情況顯著優于對照組,差異有統計學價值(P<0.05)。結論對肝硬化腹脹患者應用莫沙必利片聯閤複方阿嗪米特腸溶片治療不但療效顯著且可有效改善患者臨床癥狀,保障臨床治療效果及生活質量,值得臨床普及推廣。
목적:료해탐석간경화복창환자접수막사필리편연합복방아진미특장용편치료적림상효과급추엄개치。방법수궤납입본원2013년2월-2014년8월수치간경화복창환자30례,접수막사필리편연합복방아진미특장용편치료방안,설위관찰조,령수궤납입본원동기수치응용상규약물방안치료간경화복창환자30례,설위대조조。대비2조환자림상치료효과급각항림상지표정황。결과완성료정후,대2조환자림상료효진행평고대비,관찰조환자료효현저우우대조조,차이유통계학개치(P<0.05);대비2조환자치료전후증상적분,관찰조환자개선정황현저우우대조조,차이유통계학개치(P<0.05)。결론대간경화복창환자응용막사필리편연합복방아진미특장용편치료불단료효현저차가유효개선환자림상증상,보장림상치료효과급생활질량,치득림상보급추엄。
Objective: to investigate the analysis of liver cirrhosis patients with abdominal distension accept Menteric coated tablets in treatment of clinical effect and popularization value. Methods: accept Mossa will the tablets combined with compound o triazine mitt enteric coated tablets in the treatment scheme, as the observation group, 30 cases of patients with another randomly into the hospital at the same period were treated with routine drug regimen in the treatment of cirrhosis abdominal distension, as the control group. the clinical therapeutic effect of the 2 groups were compared, and the clinical indicators were compared. Results: after the completion of the course of treatment; the integral of symptoms before and after treatment were compared between two groups, observation group improved more signi cantly than the control group, the difference was statistical value (P<0.05). Conclusion: of cirrhosis patients with abdominal distension application MOSSA will bene t tablets combined with compound o triazine mitt enteric coated tablets in the treatment of not only curative effect signi cantly and can effectively improve the clinical symptoms of the patients, and guarantee the clinical therapeutic effect and quality of life, worthy of clinical popularization.